All compounds were then evaluated in vitro for their stability in blood serum (Figure 7) as well as their cell internalisation into NTR1-expressing HT29 cells (human colon carcinoma) and affinity toward the NTR1 (Table 6). The gene discussed is NTSR1; the disease is colon carcinoma.